FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称TAFASITAMAB
异名/同义词HUMANIZED FC ENGINEERED MONOCLONAL ANTIBODY AGAINST CD19
IMMUNOGLOBULIN, ANTI-(HUMAN CD19 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL MOR00208 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MOR00208 .KAPPA.-CHAIN, DIMER
MONJUVI
MOR00208
MOR-00208
MOR-208
TAFASITAMAB
TAFASITAMAB [INN]
TAFASITAMAB [MI]
TAFASITAMAB [USAN]
TAFASITAMAB [WHO-DD]
TAFASITAMAB CXIX [WHO-DD]
TAFASITAMAB-CXIX
XMAB5574
XMAB-5574
CAS登记号1422527-84-1
物质唯一标识(Unique Ingredient Identifier)QQA9MLH692
分子式10835
国际化合物标识(International Chemical Identifier,InChI)GH-86
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 /
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System